Key Takeaways From Pfizer Analyst Ratings
Latest Ratings for PFE Date Firm Action From To Feb 2022 Morgan Stanley Maintains Equal-Weight Jan 2022 Wells Fargo Maintains Overweight Jan 2022 B of A Securities Upgrades Neutral Buy View More Analyst Ratings for PFE View the Latest Analyst Ratings read more ​ ​Latest Ratings for PFE DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsEqual-Weight Jan 2022Wells FargoMaintainsOverweight